Skip to main content

Table 4 Sub-hazard ratio of statin, ACEi, ARB, ACEi or ARB, or any cardioprotective medication use in the 1 year following a diabetes diagnosis for women relative to men

From: Sex-based disparities in cardioprotective medication use in adults with diabetes

N = 33,294

Crude SHR (95% CI)

Adjusted* SHR (95% CI)

   Statin

0.90 (0.86 – 0.95)

0.90 (0.85 – 0.96)

   ACEi

0.91 (0.87 – 0.95)

0.90 (0.86 – 0.94)

   ARB

1.34 (1.24 – 1.43)

1.08 (0.99 – 1.17)

 ACEi or ARB

1.00 (0.97 – 1.04)

0.93 (0.89 – 0.97)

Any of the above

1.00 (0.97 – 1.04)

0.93 (0.90 – 0.97)

  1. *Adjusted for age at diabetes diagnosis, cardiovascular disease status, Chronic Disease Score, renal disease, dialysis, physician office visits, hospitalizations, days in hospital, day surgeries (all )in the 3 years prior to diabetes diagnosis, year of diabetes diagnosis and pre-existing prescription for the same medication at baseline.
  2. Abbreviations: ACEi angiotensin-converting-enzyme inhibitors, ARB angiotensin receptor blockers, SHR sub-hazard ratio.
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us